SCHEMBL3833694

SCHEMBL3833694

O=C(NC1CC2CCC1CC2)c1[c]cccc1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.46
HPGD P15428 4/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
TSHR P16473 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
EPHX2 P34913 1/20 0.41
HTT P42858 2/20 0.40
LMNA P02545 1/20 0.40
PANK3 Q9H999 1/20 0.39
CYP3A4 P08684 1/20 0.38
CNR2 P34972 1/20 0.38
TAS1R3 Q7RTX0 1/20 0.38
TAS1R1 Q7RTX1 1/20 0.38
TAS1R2 Q8TE23 1/20 0.38
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1990596 0.77 NPC1 (0.49) HPGDKDM4EALDH1A1SMN1; SMN2EPHX2
SCHEMBL1115073 0.74 NPC1 (0.47) HPGDKDM4EALDH1A1TSHRSMN1; SMN2
SCHEMBL4778685 0.74 NPC1 (0.51) HPGDKDM4EALDH1A1TSHRSMN1; SMN2
SCHEMBL14911305 0.73 NPC1 (0.54) HPGDKDM4EALDH1A1TSHRSMN1; SMN2
SCHEMBL6766655 0.72 EPHX2 (0.47) HPGDKDM4EALDH1A1SMN1; SMN2EPHX2
SCHEMBL27647235 0.70 CYP2C19 (0.46) KDM4EALDH1A1
SCHEMBL3705934 0.70 HTT (0.63) HSD17B10HPGDKDM4EALDH1A1TSHR
SCHEMBL6763548 0.69 PYGL (0.49)
SCHEMBL6763550 0.69 PYGL (0.49)
SCHEMBL4904390 0.69 GAA (0.39) KDM4EALDH1A1LMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2106396-A2 CHEMICAL COMPOUNDS 637: PYRIDOPYRIMIDINEDIONES AS PDE4 INHIBITORS AstraZeneca AB (SE) 2009-10-07 EP disclosed
WO-2008084223-A2 CHEMICAL COMPOUNDS 637: PYRIDOPYRIMIDINEDIONES AS PDE4 INHIBITORS ASTRAZENECA AB (SE) 2008-07-17 WO disclosed